Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/1/2025

Treatment of Hot Flashes in Peri- and Post-Menopausal Women

Introduction to Treatment Options

  • The American College of Obstetricians and Gynecologists recommends hormone replacement therapy (HRT) as the gold standard treatment for hot flashes in peri- and post-menopausal women, reducing hot flashes by 75-90% 1, 2

First-Line Treatment: Hormone Replacement Therapy

  • For women without contraindications, the North American Menopause Society recommends transdermal estradiol 50 μg patch, changed twice weekly, as the preferred first-line therapy for women without a uterus (post-hysterectomy) 1, 2
  • The American College of Obstetricians and Gynecologists recommends combined estrogen-progestin therapy for women with an intact uterus to prevent endometrial cancer, with micronized progesterone preferred over medroxyprogesterone acetate due to lower breast cancer and VTE risk 1

Non-Hormonal Pharmacologic Options

  • The National Comprehensive Cancer Network recommends venlafaxine as the most effective non-hormonal option, reducing hot flashes by approximately 60% 3
  • The American College of Obstetricians and Gynecologists recommends gabapentin 900 mg/day as an alternative, especially for women with sleep disturbance, reducing hot flash severity score by 46% vs 15% with placebo 3

Non-Pharmacologic Interventions

  • The North American Menopause Society recommends acupuncture as a safe and effective option for managing vasomotor symptoms, with several studies showing equivalence or superiority to venlafaxine or gabapentin in cancer survivors 3
  • The American College of Obstetricians and Gynecologists recommends cognitive behavioral therapy (CBT) and clinical hypnosis as useful adjuncts to pharmacologic therapy, reducing hot flashes 3, 1

Contraindications and Precautions

  • The American College of Obstetricians and Gynecologists recommends against initiating HRT solely for chronic disease prevention in asymptomatic women, as this increases morbidity and mortality 1
  • The North American Menopause Society recommends against prescribing estrogen-alone to women with an intact uterus, as this dramatically increases endometrial cancer risk 1

REFERENCES

1

Hormone Replacement Therapy Initiation and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

2

Transdermal Estrogen Therapy for Menopausal Symptoms [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

survivorship, version 2.2017, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2017